These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 705857)

  • 41. [Stability of blood coagulation factors in plasma frozen 6 and 18 hours after blood collection].
    Kellner S; Stöcker U; Fürst G
    Infusionsther Klin Ernahr; 1985 Aug; 12(4):208-10. PubMed ID: 4066006
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Decreased helper/suppressor cell ratios after treatment with factor VIII and IX concentrates and fresh frozen plasma.
    Ragni MV; Lewis JH; Spero JA; Bontempo FA; Rabin BS
    Am J Med; 1984 Feb; 76(2):206-10. PubMed ID: 6230009
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Platelet membrane microparticles in blood bank fresh frozen plasma and cryoprecipitate.
    George JN; Pickett EB; Heinz R
    Blood; 1986 Jul; 68(1):307-9. PubMed ID: 3087440
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factors influencing factor VIII activity in frozen plasma.
    Swärd-Nilsson AM; Persson PO; Johnson U; Lethagen S
    Vox Sang; 2006 Jan; 90(1):33-9. PubMed ID: 16359353
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factor 8 in fresh frozen plasma. Selction of units of plasma with high activity in the hospital blood bank.
    Hynes HE
    Tech Bull Regist Med Technol; 1969 Oct; 39(10):228-30. PubMed ID: 5345533
    [No Abstract]   [Full Text] [Related]  

  • 46. Preparation of cryoprecipitated factor VIII concentrates.
    Slichter SJ; Counts RB; Henderson R; Harker LA
    Transfusion; 1976; 16(6):616-26. PubMed ID: 996922
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Coagulation factor activity in platelet concentrates.
    Simon TL; Henderson R
    Transfusion; 1979; 19(2):186-9. PubMed ID: 432931
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of plasma freezing temperature, anticoagulant and time of storage on factor VIII:C activity in cryoprecipitate.
    Piedras J; Sánchez-Montero PE; Herrera FM; Córdova MS; Sánchez-Medal L
    Arch Med Res; 1993; 24(1):23-6. PubMed ID: 8292873
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thaw-siphon technique for production of cryoprecipitate concentrate of factor VIII.
    Mason EC
    Lancet; 1978 Jul; 2(8079):15-7. PubMed ID: 78212
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The bioequivalence of frozen plasma prepared from whole blood held overnight at room temperature compared to fresh-frozen plasma prepared within eight hours of collection.
    Dumont LJ; Cancelas JA; Maes LA; Rugg N; Whitley P; Herschel L; Siegel AH; Szczepiorkowski ZM; Hess JR; Zia M
    Transfusion; 2015 Mar; 55(3):476-84. PubMed ID: 25233805
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of blood components separated from donated whole blood after an overnight holding at room temperature with the buffy coat method.
    Lu FQ; Kang W; Peng Y; Wang WM
    Transfusion; 2011 Oct; 51(10):2199-207. PubMed ID: 21492181
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate.
    Prowse CV; Griffin B; Pepper DS; Dickson AJ; McQuillan TA; Dickson IH; Foster PR
    Thromb Haemost; 1981 Oct; 46(3):597-601. PubMed ID: 6797090
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of fibrinogen content in cryoprecipitate by temperature manipulation during plasma processing.
    Farrugia A; Grasso S; Douglas S; Harrap R; Oates A; Young I; James J; Whyte G
    Transfusion; 1992 Oct; 32(8):755-9. PubMed ID: 1412684
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of factor VIII-rich cryoprecipitate and the plasma fibronectin-rich, heparin-precipitable fraction prepared from single-donor plasma units.
    Menitove JE; Amrani DL; Meh D; Frenzke M; Mosesson MW
    Transfusion; 1987; 27(6):491-5. PubMed ID: 3500532
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative analysis of activity of coagulation Factors V and VIII and level of fibrinogen in fresh frozen plasma and frozen plasma.
    Dogra M; Sidhu M; Vasudev R; Dogra A
    Asian J Transfus Sci; 2015; 9(1):6-8. PubMed ID: 25722564
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Five-day stability of thawed plasma: solvent/detergent-treated plasma comparable with fresh-frozen plasma and plasma frozen within 24 hours.
    Neisser-Svae A; Trawnicek L; Heger A; Mehta T; Triulzi D
    Transfusion; 2016 Feb; 56(2):404-9. PubMed ID: 26419404
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monitoring oral anticoagulant treatment from plasma stored for up to 48 hours and frozen plasma.
    Grau E; Tenias JM; Olaso MA; Ferrando I; Juan MT; Pastor E; Perez A; Real E
    Haematologica; 1999 Jul; 84(7):633-6. PubMed ID: 10406906
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coagulation parameters of CPD fresh-frozen plasma and CPD cryoprecipitate-poor plasma after storage at 4 degrees C for 28 days.
    Smak Gregoor PJ; Harvey MS; Briët E; Brand A
    Transfusion; 1993 Sep; 33(9):735-8. PubMed ID: 8212120
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Platelet preservation. IV. Preparation and cryopreservation of platelet concentrates from fresh and overnight-stored human blood.
    Odink J; de Wit JJ; Janssen CL; Prins HK
    Transfusion; 1978; 18(1):21-8. PubMed ID: 625780
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of an 8-hour holding period on in vivo and in vitro properties of red cells and factor VIII content of plasma after collection in a red cell additive system.
    Moroff G; Holme S; Heaton WA; Kevy S; Jacobson M; Popovsky M
    Transfusion; 1990; 30(9):828-32. PubMed ID: 2122558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.